BYASMay 2110 minNatural Product Therapeutics and COVID-19: The Case for Clinical Development of Spirulina ExtractsErik Reynolds MS and Leonard Lerer MBChB MBA Abstract Abstract— In the light of the current paucity of therapeutic options for acute coronavirus 2019 (COVID-...
BYASMay 154 minBiomedical Research and Covid-19 — Is More of the Same Enough?Science must work with and not against nature.
BYASMay 131 minFeeding the Pilot Digester, an update from the Algae Digester laboratory (AD-LAB)Back of the Yards Algae Sciences and Bubbly Dynamics began operating our pilot-scale digester this month. This project simulates the conditions of our large-...
BYASMay 111 minBYAS 2020 Row Crop Biostimulant R&D programBuilding on our successful initial 2019 studies with BYAS-A601, our lead agricultural biostimulant, we are working with Tidewater Agronomics in North Carolin...
BYASMay 44 minThe Selfish Trip — Psychedelics, Science and Social JusticeI am new to the psychedelic ecosystem. When I meet or listen to company founders, activists, investors and other players in this nascent sector speak, their ...
BYASApr 152 minBack of the Yards Algae Sciences (BYAS) to Webcast Live at the KCSA Cannabis/Psychedelic ConferenceBack of the Yards Algae Sciences (BYAS) to Webcast Live at the KCSA Cannabis/Psychedelic Virtual Investor Conference on April 20th Invitation to individual a...
